According to the recently-published report by Persistence Market Research, the global market for gene expression analysis will reflect a steady growth during the forecast period, 2017-2022.
By the end of 2022, the global gene expression analysis market is predicted to surpass US$ 4,500 Mn valuation, reflecting a robust CAGR in terms of revenues. The study throws a light on various factors influence the dynamics of global gene expression analysis market, and offers insightful projections, the highlights of which are mentioned below.
To remain ‘ahead’ of your competitors, request for a samples@
https://www.persistencemarketresearch.com/samples/17995
The healthcare vertical is on the verge of shifting point-of-care services to a wider constellation of settings, inclusive of the patients’ own homes. This has, in turn, given rise to value-based payment methodologies. With far-flung patients getting an access to high-speed internet, digital care is becoming the cornerstone. On these grounds, One Medical, an IPO backed by Google, is turning out to be a benchmark with regards to digital-first primary care, wherein concierge service is offered on payment of annual fee.
This digitization is expected to empower the healthcare vertical across all the geographies in the near future. Persistence Market Research has its prodigal team in the form of consultants and analysts to keep a tab on the latest happenings in the healthcare vertical along with the probable calls to action.
Gene Expression Analysis Market: Regional Forecast
Through 2022, North America is anticipated to hold a leading position in the global market for gene expression analysis. Most of the companies operating in the expansion of global gene expression analysis market are based in the US. Moreover, North American research institutes contributing to the field of functional genomics continue to support the development of new drugs derived from gene expression analysis studies. Drug discovery is a key application of gene expression analysis, and the US healthcare markets are observed as lucrative grounds for players in the global gene expression analysis market.
- North America’s gene expression analysis market is pegged to be reach a billion dollar valuation by the end of 2017. The report projects that throughout the forecast period, the gene expression analysis market in North America will reflect a robust CAGR, wherein the US market will be observed as the largest contributor to this growth.
- Europe is also expected to reflect impressive growth as the gene expression analysis market in this region is poised to create an incremental opportunity of over US$ 200 Mn between 2017 and 2022.
- The gene expression analysis market in Asia-Pacific excluding Japan (APEJ) region is anticipated to record fastest growth. To the contrary, Japan’s gene expression analysis market is expected to reflect lowest CAGR during the forecast period.
For critical insights on this market, request for ask an expert here @
https://www.persistencemarketresearch.com/ask-an-expert/17995
Widespread Adoption of Northern Blotting Technology
On the basis of technology, the report projects that northern blotting will be at the forefront of adoption, and will reflect highest share on global revenues of gene expression analysis market. DNA microarrays and PCR techniques are also projected to gain traction as preferred technologies used for synthesizing functional gene products through gene expression analysis. Advancements in RNA-sequencing, 2-D gel electrophoresis, western blotting, immunoassays, ChIP, mass spectrometry and other technologies are also expected to influence the future prospects of global gene expression analysis market.
The report further projects that gene expression analysis will find higher traction in drug discovery & development applications. Towards the end of the forecast period, application of gene expression analysis in drug discovery & development is anticipated to procure over US$ 1,200 Mn in global revenues. Concurrently, the demand for gene expression analysis products with low- to mid- plex capacity will also witness considerable uptake during the forecast period. The report also anticipates that sales of products – kits & reagents – will reflect a sizeable share on the value of global gene expression analysis market throughout the forecast period. By the end of 2022, kits & reagents will register over one-third share on the global market revenues for gene expression analysis.
The report has also profiled key players in the global market for gene expression analysis, which include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., General Electric Company, Luminex Corporation, Illumina, Inc., Oxford Gene Technology IP, PerkinElmer, Inc., QIAGEN NV, Roche Holding AG, and Thermo Fisher Scientific, Inc.
For in-depth competitive analysis, buy now@
https://www.persistencemarketresearch.com/checkout/17995
Read More Trending “PMR Exclusive Article”
- Global Market Study on Hemoglobinopathy: https://www.persistencemarketresearch.com/market-research/hemoglobinopathy-market.asp
- Global Market Study on Diabetic Gastroparesis Treatment: https://www.persistencemarketresearch.com/market-research/diabetic-gastroparesis-market.asp
About us
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com